Subscribe
shutterstock_1013219203_kateryna_kon
Kateryna Kon / Shutterstock.com
31 October 2019Big PharmaSaman Javed

Global Drug Facility adds new TB drug to its catalogue

The Global Drug Facility, which provides tuberculosis (TB) treatments to those in need in 150 countries, has listed a new drug to its product catalogue.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
TAG supports opposition of Sanofi TB drug patents in India
9 December 2019   Treatment Action Group, a US-based organisation focused on research of diseases such as HIV/AIDS and tuberculosis, has applauded an opposition that aims to block Sanofi from patenting a new TB drug in India.
Big Pharma
US considers shortening marketing exclusivity to push forward USMCA
3 December 2019   The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.
Big Pharma
J&J invests $500m into global HIV and TB treatment
10 October 2019   Johnson & Johnson has committed $500 million to research and development programmes over the next four years in a bid to eliminate HIV and tuberculosis across the world by 2030.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Big Pharma
TAG supports opposition of Sanofi TB drug patents in India
9 December 2019   Treatment Action Group, a US-based organisation focused on research of diseases such as HIV/AIDS and tuberculosis, has applauded an opposition that aims to block Sanofi from patenting a new TB drug in India.
Big Pharma
US considers shortening marketing exclusivity to push forward USMCA
3 December 2019   The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.
Big Pharma
J&J invests $500m into global HIV and TB treatment
10 October 2019   Johnson & Johnson has committed $500 million to research and development programmes over the next four years in a bid to eliminate HIV and tuberculosis across the world by 2030.

More on this story

Big Pharma
TAG supports opposition of Sanofi TB drug patents in India
9 December 2019   Treatment Action Group, a US-based organisation focused on research of diseases such as HIV/AIDS and tuberculosis, has applauded an opposition that aims to block Sanofi from patenting a new TB drug in India.
Big Pharma
US considers shortening marketing exclusivity to push forward USMCA
3 December 2019   The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.
Big Pharma
J&J invests $500m into global HIV and TB treatment
10 October 2019   Johnson & Johnson has committed $500 million to research and development programmes over the next four years in a bid to eliminate HIV and tuberculosis across the world by 2030.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler